ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00
- $186.15bn
- $193.77bn
- $40.11bn
- 85
- 26
- 75
- 66
REG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - AIM - AIM Notice - 19/10/2022
AnnouncementRCS - Arxada AG - Arxada Enhances Focus in Microbial Control
AnnouncementREG - Abbott Laboratories - Abbott Laboratories Files Rule 425 Document <Origin Href="QuoteRef">ABT.N</Origin>
AnnouncementREG - Abbott Laboratories - Abbott Laboratories files Rule 425 Document <Origin Href="QuoteRef">ABT.N</Origin>
AnnouncementREG - Abbott Laboratories - Abbott Laboratories Files Form 8-K <Origin Href="QuoteRef">ABT.N</Origin>
AnnouncementREG - Abbott Laboratories - 3rd Quarter Results <Origin Href="QuoteRef">ABT.N</Origin> - Part 2
Announcement